Intellectual Property NFTs provide secure and transparent proof of ownership. Researchers can assert rights, raise funds, and monetize innovation. Learn more in our docs.
Name | Valuation | Minted At | Category | Owner |
|---|---|---|---|---|
KISS1R: Phase 1 Wet-Lab — KP-10 Reference + ncAA Leads C1-01, C1-02 | $10,000.00 | Peptide therapeutics — Fertility / Hypogonadism / KISS1R–GPR54 agonism | 0x6a41B…B2173 | |
OX2R-004: Phase 1 Wet-Lab — Reference + Stabilised Variant (S1) | $7,750.00 | Peptide therapeutics — CNS / ADHD / orexin receptor agonism | 0xDa935…da668 | |
TRAIN by Holi | €150,000.00 | longevity | 0xbCFcc…92661 | |
Spectruth DAO’s Proprietary Synthetic Ibogaine Process Patent: Pioneering Sustainable Solutions for Trauma Healing | $75,000.00 | Post-Traumatic Stress Disorder (PTSD) | 0x9a00e…dC6A4 | |
LONG COVID LABS | $100,000.00 | Infectious Diseases | 0xab7ca…36316 | |
Follistatin Gene Therapy for Canine Arthritis and Healthspan | $0.00 | Arthritis | 0x7b940…fDBD1 | |
Advancing Skin Longevity: Decentralized Trials for Novel Anti-Aging Formulations | $0.00 | Skincare | 0x4e849…AFFe7 | |
Relieva | $150,000.00 | Pain Research 26 | 0xab67b…db5C2 |